Fig. 4From: Screening and identifying of biomarkers in early colorectal cancer and adenoma based on genome-wide methylation profilesThe proportion of distribution for differential methylation CpG markers and descriptive analysis of co-differentially methylated sites in colorectal cancers and adenomas. A The proportion of distribution for differential methylation CpG markers in adenoma and colorectal cancer respectively. The middle section represents the co-distribution for differential methylation CpG markers. The blue area represents a unique marker of adenoma, and the yellow portion is a unique marker of colorectal. B The distribution of co-differential methylation CpGs and co-hyper/hypo-methylation CpGs was analyzed on CpG island-related regions. C The distribution of co-differential methylation CpGs and co-hyper/hypo-methylation CpGs was analyzed on the CpG island of the promoterBack to article page